4.7 Review

Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer

Journal

NATURE REVIEWS CANCER
Volume 8, Issue 6, Pages 438-449

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2396

Keywords

-

Categories

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [P30-CA01687, R37-CA76584, R21-CA125173] Funding Source: Medline
  3. NIGMS NIH HHS [R01 GM057587, R01 GM057587-11, R01-GM57587] Funding Source: Medline

Ask authors/readers for more resources

The maintenance and preservation of distinct phases during the cell cycle is a highly complex and coordinated process. It is regulated by phosphorylation - through the activity of cyclin-dependent kinases (CDKs) - and protein degradation, which occurs through ubiquitin ligases such as SCF (SKP1 - CUL1 - F-box protein) complexes and APC/C (anaphase-promoting complex/cyclosome). Here, we explore the functionality and biology of the F-box proteins, SKP2 (S-phase kinase-associated protein 2) and beta-TrCP (beta-transducin repeat-containing protein), which are emerging as important players in cancer biogenesis owing to the deregulated proteolysis of their substrates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available